- 2026-04-20
-
NOF Exhibiting Latest LNP Technology at AACR Annual Meeting 2026
Tokyo, Japan — NOF CORPORATION is pleased to announce its participation in the ongoing American Association for Cancer Research Annual Meeting 2026 (AACR 2026) which is taking place at the San Diego Convention Center, San Diego, CA, USA from April 17 to 22. AACR 2026 highlights the latest breakthroughs in cancer research and clinical trials. […]
- 2026-04-20
-
NOF to Present Advanced LNP Technologies at PEGS BOSTON 2026
Tokyo, Japan – April 6, 2026 – NOF CORPORATION is pleased to announce its participation in the upcoming 22nd Annual PEGS Boston, which will be held at the Omni Boston Hotel at the Seaport, Boson, MA, USA from May 11 to 15, 2026. The company is proud to be a Corporate Sponsor for PEGS Boston […]
- 2026-03-24
-
NOF to Exhibit at ARVO 2026 from May 3 – 6
Tokyo, Japan — NOF CORPORATION is pleased to announce its participation in the upcoming ARVO 2026 Annual Meeting(*1) to be held at the Colorado Convention Center, Denver, CO, USA from May 3 to 7. At the event, NOF CORPORATION will highlight its YT-LIPIDURE® series, a major product line for eye drops, at booth #5030 from May […]
- 2026-03-13
-
NOF to Show Advanced Materials and Customization Services at SFB 2026
Tokyo, Japan — NOF CORPORATION is pleased to announce its participation in the upcoming SFB 2026 Annual Meeting & Exposition, which will be held at the Hyatt Regency Atlanta, Atlanta, GA from March 25 to 28. As a part of the event, NOF CORPORATION will showcase its products and services for biomaterials at Booth #407. […]
- 2026-03-09
-
NOF to Present Advanced DDS Technologies at LNP Summit 2026, Boston
Tokyo, Japan — NOF CORPORATION is pleased to announce its participation in the upcoming 5th Annual LNP Formulation & Process Development Summit, which will be held at The Westin Boston Seaport District, Boston, MA, USA from April 6 to April 8, 2026. The company is proud to be a Program Partner for the summit. As […]
- 2026-02-09
-
NOF to Exhibit and Present at Drug Delivery Summit 2026
Tokyo, Japan — NOF CORPORATION is pleased to announce its participation in the upcoming 6th Annual Drug Delivery Summit 2026, which will be held at the Sheraton San Diego Resort, San Diego, CA, USA on February 23 and 24. The company is a Platinum Sponsor of the event. As a part of the event, NOF […]
- 2026-01-30
-
Aichi Works ISO 14001 Certification Renewed; LS Aichi Plant Added to Scope
Tokyo, Japan — NOF CORPORATION is pleased to announce that the ISO 14001 certification for its Aichi Works was renewed in January 2026, and that the newly completed LS Aichi Plant has been added to the certification scope. LS Aichi Plant, located within Aichi Works, was newly completed in late 2025, and is included in […]
- 2026-01-30
-
First TV Commercial for the Life Science Division to Air on TV TOKYO (Kanto area)
Tokyo, Japan — NOF CORPORATION will soon air a television commercial featuring the Life Science Division. This marks the first time the Company has launched a TV commercial. Details Broadcast station: TV TOKYO, Japan Area: Kanto local area — Tokyo, Kanagawa, Saitama, Chiba, Ibaraki, Tochigi, Gunma Dates: Wednesday, February 11, 2026 Wednesday, February 25, 2026 […]
- 2026-01-06
-
NOF to Attend BIO Partnering at JPM Week 2026 from January 12 to 15
Tokyo, Japan — NOF CORPORATION is pleased to announce that the company will attend BIO Partnering at JPM Week 2026, which will be held at San Francisco Marriott Marquis, 780 Mission Street, San Francisco, CA, U.S.A. from January 12 to 15. During the event, representatives from NOF CORPORATION will be available whether in person or […]
- 2025-12-19
-
NOF‑supported LNP study reported in Journal of Controlled Release
Tokyo, Japan — NOF CORPORATION is pleased to announce that a collaborative study using NOF’s ionizable lipid materials has been published in the Journal of Controlled Release (389 (2026) 114414). The paper, “Combination of ionizable lipids with oleic acid and vitamin E scaffolds for RNA cancer vaccine delivery,” reports the development and evaluation of dual‑ionizable […]
